| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/14/2004 | CA2073113C Conjugates |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004077058A1 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr) |
| 09/10/2004 | WO2004076677A2 Monoclonal antibody production by ebv transformation of b cells |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076645A2 Compositions and methods for cytomegalovirus treatment |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076639A2 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 09/10/2004 | WO2004076634A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
| 09/10/2004 | WO2004076631A2 Biologically active native biomatrix composition |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076619A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 09/10/2004 | WO2004076488A1 A molecule which binds cd80 and cd86 |
| 09/10/2004 | WO2004076486A1 Method for reducing levels of c-reactive protein |
| 09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
| 09/10/2004 | WO2004075875A1 Dosage form having a saccharide matrix |
| 09/10/2004 | WO2004075855A2 Process for in vivo treatment of specific biological targets in bodily fluid |
| 09/10/2004 | WO2004075850A2 Polyvalent immunogen |
| 09/10/2004 | WO2004075838A2 Method and compositions for the treatment of meconium aspiration syndrome |
| 09/10/2004 | WO2004075836A2 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075829A2 Adjuvanted influenza vaccine |
| 09/10/2004 | WO2004075811A2 Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/10/2004 | WO2004075723A2 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | WO2004075636A1 Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease |
| 09/10/2004 | WO2004062583A3 Vaccine and method for preventing biofilm formation |
| 09/10/2004 | WO2004058799A3 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 09/10/2004 | WO2004041864A3 Passive hyperimmune antibody therapy in the treatment of anthrax |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 09/10/2004 | WO2004021772A3 Immune cloning and uses thereof |
| 09/10/2004 | WO2004020579A3 Method of humanizing immune system molecules |
| 09/10/2004 | WO2004019886A3 Methods for up-regulating antigen expression in tumors |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003076643A3 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/10/2004 | WO2003076579A3 Cancer-linked gene as target for chemotherapy |
| 09/10/2004 | WO2003064618A3 Immune response replication in cloned animals |
| 09/10/2004 | WO2003038061A3 Ehrlichia disulfide bond formation proteins and uses thereof |
| 09/10/2004 | WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | CA2519193A1 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | CA2517258A1 Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2517052A1 Polyvalent immunogen |
| 09/10/2004 | CA2517037A1 Method for reducing levels of c-reactive protein |
| 09/10/2004 | CA2516832A1 A molecule which binds cd80 and cd86 |
| 09/10/2004 | CA2516640A1 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis |
| 09/10/2004 | CA2514667A1 Adjuvanted influenza vaccine |
| 09/10/2004 | CA2514500A1 Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease |
| 09/10/2004 | CA2514329A1 Methods for the treatment of renal cell carcinoma |
| 09/09/2004 | US20040177395 Immune cloning and uses thereof |
| 09/09/2004 | US20040177394 Using nuclear transfer of preferentially immune responsive genomes to generate vaccinated transgenic mammals; tissue engineering |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176598 Azaindoles coupled with piperidine or piperazine and linker to cyclic group |
| 09/09/2004 | US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176314 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 09/09/2004 | US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 09/09/2004 | US20040176282 Cellular delivery and activation of polypeptide-nucleic acid complexes |
| 09/09/2004 | US20040175825 for drug screening/diagnostics for inflammation, arthritis and cancer; genetic engineering; kits |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175758 Novel Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 09/09/2004 | US20040175740 Using proopiomelanocortin animal mutant to identify modulators of weight and pancreatic disorders |
| 09/09/2004 | US20040175739 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175705 Expression vector for transformation and expression of heterologous polypeptides in methylococcal/methanotrophic bacteria; bioreactors |
| 09/09/2004 | US20040175441 plant-derived recombinant amino acid sequence in the manufacture of a medicament for the prevention or treatment of disease in fish |
| 09/09/2004 | US20040175440 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 09/09/2004 | US20040175407 Microorganism coating components, coatings, and coated surfaces |
| 09/09/2004 | US20040175398 Oral smallpox vaccine production and methods to evaluate safety, efficacy, and potency of orally delivered vaccine |
| 09/09/2004 | US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
| 09/09/2004 | US20040175394 Prevention and treatment of amyloidogenic disease |
| 09/09/2004 | US20040175393 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon |
| 09/09/2004 | US20040175392 Compositions and methods for the generation of protective immune responses against malaria |
| 09/09/2004 | US20040175391 Diluting manure in aqueous medium to slurry; separating unwanted fecal matter; solid/liquid phase centrifuging; diluting high density liquid fraction to specific gravity wherein the oocysts are no longer buoyant; free of potassium dichromate |
| 09/09/2004 | US20040175383 Administering to mammal a protease inhibitor comprising antitrypsin and/or ilomastat |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | US20040175369 Stat3 antagonists and their use as vaccines against cancer |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/08/2004 | EP1454989A1 Infectious HCV pseudo-particles containing native functional E1 and E2 envelope proteins |
| 09/08/2004 | EP1454988A1 Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
| 09/08/2004 | EP1454987A1 Polypeptides translocated into cells by the VirB/VirD4 type IV secretion system and uses thereof |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454142A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 09/08/2004 | EP1454140A2 Diagnosis and treatment of atherosclerosis |
| 09/08/2004 | EP1453965A2 Dna vaccine |
| 09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
| 09/08/2004 | EP1453957A2 Method of large scale production of hepatitis a virus |
| 09/08/2004 | EP1453862A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453853A2 Mixture of peptides originating from a nef protein and applications thereof |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453540A2 Modulation of lir function to treat rheumatoid arthritis |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453538A2 Method of purifying hepatitis a virus particles and vaccine preparation |